Results 171 to 180 of about 700,736 (296)

Safety and effectiveness of Bian-stone and moxibustion in treatment of meibomian gland dysfunction. [PDF]

Int J Ophthalmol
Hao R, Bai XM, Jing DL, Jiang XD, Li XM.
europepmc   +1 more source

Real‐world insights on switching aflibercept dosage for enhanced outcomes in age‐related macular degeneration (RISE‐AMD): Safety data

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate real‐world safety experience with aflibercept 8 mg in a large case series of patients with neovascular age‐related macular degeneration (nAMD). Methods Due to a high proportion of patients on short treatment intervals, patients with nAMD at a Danish tertiary retina clinic were systematically switched to aflibercept 8 mg ...
Mary Graciya Karunainathan, Celine Lee, Kaweh Daniel Zohalinejad, Mads Odgaard Mæng, Nanna Würtz Fabrin, Sigurrós Jónsdóttir, Anne Kjærsgaard Hassing, Søren Kveiborg Yde, Charles C. Wykoff, Henrik Vorum, Yousif Subhi, Marie Ørskov, Lasse Jørgensen Cehofski   +12 more
wiley   +1 more source

Anteroplacement of the Mucocutaneous Junction and Goblet Cell Expansion: Microanatomic Remodeling of the Human Eyelid Margin. [PDF]

Invest Ophthalmol Vis Sci
Yang X, Zeng M, Zhang X, Liang L, Lin H.
europepmc   +1 more source

Vision‐related quality of life following trabeculectomy versus Baerveldt glaucoma implant: Five‐year results from a randomized clinical trial

Acta Ophthalmologica, EarlyView.
Abstract Purpose To assess the vision‐related quality of life (VRQoL) in glaucoma patients over 5 years after primary Baerveldt glaucoma implant (BGI) or trabeculectomy (TE) using a secondary analysis of a randomized clinical trial. Methods Patients were randomized to undergo TE or receive a BGI.
Ionela Popescu‐Giovanitsas, Jarinne E. Woudstra‐de Jong, Johannes R. Vingerling, Peter W. T. de Waard, Pieter W. M. Bonnemaijer   +4 more
wiley   +1 more source

Highlighting Ophthalmic Adverse Effects Associated with Isotretinoin. [PDF]

Life (Basel)
Pan JT, Daniel BS, Tan B, Lim BXH, Murrell DF, Watson SL, Lim CHL.   +6 more
europepmc   +1 more source

Warthin's tumour of the eye lid.

Indian journal of ophthalmology, 1990
A, Mathur, M L, Mehrotra, U, Dhaliwal
openaire   +1 more source

The role of pain in Graves' orbitopathy: Associations with clinical activity and quality of life

Acta Ophthalmologica, EarlyView.
Abstract Purpose Pain is included in the clinical activity score (CAS) as an indicator of inflammatory activity in Graves' orbitopathy (GO), yet its clinical relevance has not been systematically evaluated. We therefore investigated the relationship between pain, other inflammatory signs and quality of life (QoL), and assessed the effect of intravenous
Gijsbert J. Hötte, Willem A. Dik, Ronald O. B. de Keizer, Sodaba Khatab, Marco Medici, Maaike de Bie, P. Martin van Hagen, Dion Paridaens   +7 more
wiley   +1 more source

Eyelid and tear-film factors associated with contact lens discomfort symptom burden among wearers attending after-care in Kisumu County, Kenya: a clinic-based cross-sectional study. [PDF]

BMC Ophthalmol
Muga S, Okenwa-Vincent EE, Ragot A, Signes-Soler I.   +3 more
europepmc   +1 more source

Three years of ocular proton therapy in the Netherlands, clinical results

Acta Ophthalmologica, EarlyView.
Abstract Purpose Uveal melanoma (UM) is a rare cancer with rising number of diagnosis (143 diagnoses in 1990 to 226 in 2023) in the Netherlands. Most patients are treated locally with Ruthenium‐106 brachytherapy (±102/year). Patients were referred for proton therapy (PT) to Switzerland in the past, but PT is available in the Netherlands from January ...
C. Rasch, M. Marinkovic, L. Pors, E. Kilic, N. Naus, S. Yavuzyigitoglu, P. A. Bakker, C. van Rij, J. W. Beenakker, J. Bleeker, A. Schalenbourg, A. Pica, J. Hrbacek, N. Horeweg, K. Vu   +14 more
wiley   +1 more source

Comparison of Meibomian Gland Loss Between Pediatric Patients with Blepharo-Keratoconjunctivitis and Age-Matched Controls Using Non-Contact Meibography. [PDF]

J Clin Med
Jeong J, Paik JS, Na KS, Cho K.
europepmc   +1 more source